## **Core Concept**
E-cadherin is a transmembrane glycoprotein that plays a crucial role in cell-cell adhesion, particularly in epithelial tissues. It is encoded by the CDH1 gene. Deficiencies or mutations in the E-cadherin gene are associated with disrupted cell adhesion, leading to various pathological conditions, including cancer.

## **Why the Correct Answer is Right**
The correct answer, **CDH1**, is directly related to the E-cadherin gene. Mutations in the CDH1 gene have been linked to hereditary diffuse gastric cancer (HDGC) and lobular breast cancer. E-cadherin acts as a tumor suppressor, and its deficiency can lead to loss of cell adhesion, contributing to the development and progression of cancer.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Not provided, but any incorrect gene name or symbol would be wrong due to the specificity of genetic nomenclature and the direct association of CDH1 with E-cadherin.
- **Option B:** Similarly, without a specific option provided, any gene not directly associated with E-cadherin or cell adhesion in the context of known diseases would be incorrect.
- **Option C:** As with Option B, any gene not directly linked to E-cadherin function or related pathologies would not be correct.
- **Option D:** This option would also be incorrect for the same reasons as Options A, B, and C, assuming it does not correspond to CDH1.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **hereditary diffuse gastric cancer (HDGC)** is associated with germline mutations in the CDH1 gene. Individuals with a family history of HDGC or certain types of breast cancer may benefit from genetic screening for CDH1 mutations. Prophylactic gastrectomy may be considered in those found to have a CDH1 mutation, given the high risk of developing diffuse gastric cancer.

## **Correct Answer:** D. CDH1.